Stockholm - Free Realtime Quote SEK

Clinical Laserthermia Systems AB (publ) (CLS-B.ST)

Compare
3.2600
+0.1400
+(4.49%)
As of 4:44:41 PM GMT+1. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
15,196.0000
8,273.0000
6,268.0000
2,245.0000
1,332.0000
Cost of Revenue
10,041.0000
5,276.0000
9,058.0000
5,875.0000
456.0000
Gross Profit
5,155.0000
2,997.0000
-2,790.0000
-3,630.0000
876.0000
Operating Expense
68,346.3670
68,478.3670
64,650.3940
56,984.4510
52,686.8140
Operating Income
-63,191.3670
-65,481.3670
-67,440.3940
-60,614.4510
-51,810.8140
Net Non Operating Interest Income Expense
-3,020.8770
-9,458.8770
-11,189.7560
-6,370.7180
-3,232.6730
Pretax Income
-69,058.0000
-80,875.0000
-71,265.0000
-64,141.0000
-57,939.0000
Net Income Common Stockholders
-68,039.0000
-79,792.0000
-70,660.0000
-63,615.0000
-57,939.0000
Diluted NI Available to Com Stockholders
-68,039.0000
-79,792.0000
-70,660.0000
-63,615.0000
-57,939.0000
Basic EPS
-2.29
-22.89
-163.22
-69.24
-66.41
Diluted EPS
-2.29
-22.89
-163.22
-69.24
-66.41
Basic Average Shares
13,931.7070
3,486.5090
432.9160
918.7880
872.4090
Diluted Average Shares
13,931.7070
3,486.5090
432.9160
918.7880
872.4090
Total Operating Income as Reported
-63,643.0000
-65,933.0000
-67,442.0000
-60,682.0000
-52,096.0000
Rent Expense Supplemental
--
--
--
--
805.1640
Total Expenses
78,387.3670
73,754.3670
73,708.3940
62,859.4510
53,142.8140
Net Income from Continuing & Discontinued Operation
-68,039.0000
-79,792.0000
-70,660.0000
-63,615.0000
-57,939.0000
Normalized Income
-71,511.3360
-80,175.3360
-71,834.4350
-63,615.0000
-57,939.0000
Interest Income
301.4030
301.4030
--
0.1280
--
Interest Expense
3,322.4850
9,760.4850
10,972.4870
6,405.2000
3,271.1290
Net Interest Income
-3,020.8770
-9,458.8770
-11,189.7560
-6,370.7180
-3,232.6730
EBIT
-65,735.5150
-71,114.5150
-60,292.5130
-57,735.8000
-54,667.8710
EBITDA
-63,116.5150
-68,406.5150
-57,842.5130
-54,947.8000
-51,611.8710
Reconciled Cost of Revenue
10,041.0000
5,276.0000
9,058.0000
5,875.0000
456.0000
Reconciled Depreciation
2,619.0000
2,708.0000
2,450.0000
2,788.0000
3,056.0000
Net Income from Continuing Operation Net Minority Interest
-68,039.0000
-79,792.0000
-70,660.0000
-63,615.0000
-57,939.0000
Total Unusual Items Excluding Goodwill
3,472.3360
383.3360
1,174.4350
--
--
Total Unusual Items
3,472.3360
383.3360
1,174.4350
--
--
Normalized EBITDA
-66,588.8510
-68,789.8510
-59,016.9480
-54,947.8000
-51,611.8710
12/31/2020 - 4/16/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MONI.ST Monivent AB
0.3180
+1.92%
 
TENDO.ST Tendo AB
0.0116
-9.37%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1268
-0.94%
 
INTEG-B.ST Integrum AB (publ)
18.05
+0.28%
 
QLIFE.ST Qlife Holding AB (publ)
2.3200
+9.43%
 
QLINEA.ST Q-linea AB (publ)
0.4010
-19.80%
 
OSSD.ST OssDsign AB (publ)
11.52
+2.13%
 
XVIVO.ST Xvivo Perfusion AB (publ)
440.00
-7.47%
 
ACARIX.ST Acarix AB (publ)
0.2480
-0.60%
 
CLPT ClearPoint Neuro, Inc.
15.05
+2.42%